Adverse drug and device reactions in the oral cavity: Surveillance and reporting |
| |
Authors: | Athanasios I. Zavras Gregory E. Rosenberg Jared D. Danielson Vassiliki M. Cartsos |
| |
Abstract: | BackgroundAccording to the U.S. Centers for Disease Control and Prevention, 48 percent of Americans (roughly 144 million people) used at least one prescribed medication in the preceding month; 11 percent used five or more. The authors describe the U.S. Food and Drug Administration's (FDA's) MedWatch program, the safety surveillance system for drugs and devices in the United States, and the dentist's role with regard to voluntary reporting of adverse effects (AEs). They also identify the most frequent AEs in the oral cavity as reported in the FDA Adverse Event Reporting System (FAERS).MethodsThe authors reviewed the literature regarding MedWatch, and they mined data in the FAERS public database for the 100 most commonly prescribed medications and their associated AEs.ResultsPharyngitis was the most common AE. Cough, dysgeusia and dysphagia also were common.ConclusionThe MedWatch program and its related databases contain useful information about AEs of pharmaceuticals and devices manifested in the oral cavity. Increased participation in the reporting of suspected adverse reactions will improve the national surveillance system and ultimately will protect patients' safety.Practical ImplicationsAs pharmaceutical consumption increases exponentially for a growing segment of the population, and as innovation in dental technology and devices flourishes, dentists have a distinct role in safeguarding patients' well-being. Promptly reporting AEs in the oral cavity improves quality of care and protects patients' well-being. |
| |
Keywords: | Epidemiology consumer product safety drugs U.S. Food and Drug Administration implants legal liability oral medicine postmarketing product surveillance safety management AE" },{" #name" :" keyword" ," $" :{" id" :" cekeyw110" }," $$" :[{" #name" :" text" ," _" :" Adverse effect FAERS" },{" #name" :" keyword" ," $" :{" id" :" cekeyw130" }," $$" :[{" #name" :" text" ," _" :" FDA Adverse Event Reporting System FDA" },{" #name" :" keyword" ," $" :{" id" :" cekeyw150" }," $$" :[{" #name" :" text" ," _" :" Food and Drug Administration HIPAA: Health Insurance" },{" #name" :" keyword" ," $" :{" id" :" cekeyw170" }," $$" :[{" #name" :" text" ," _" :" Portability and Accountability Act MAUDE" },{" #name" :" keyword" ," $" :{" id" :" cekeyw190" }," $$" :[{" #name" :" text" ," _" :" Manufacturer and User Facility Device Experience Med-DRA" },{" #name" :" keyword" ," $" :{" id" :" cekeyw210" }," $$" :[{" #name" :" text" ," _" :" Medical Dictionary for Regulatory Activities PMA" },{" #name" :" keyword" ," $" :{" id" :" cekeyw230" }," $$" :[{" #name" :" text" ," _" :" Premarket approval |
本文献已被 ScienceDirect 等数据库收录! |
|